Literature DB >> 29655826

Exploiting the Natriuretic Peptide Pathway to Preserve Glomerular Filtration in Heart Failure.

Wilfried Mullens1, Pieter Martens2.   

Abstract

Keywords:  glomerular filtration; heart failure; outcome; sacubitril/valsartan

Mesh：

Substances：

Year:  2018        PMID： 29655826     DOI： 10.1016/j.jchf.2018.02.017

Source DB:  PubMed          Journal:  JACC Heart Fail        ISSN： 2213-1779            Impact factor:   12.035


× No keyword cloud information.
  10 in total

1.  The nephroprotective effect of sacubitril/valsartan in heart failure: insights from the real-life clinical setting.

Authors:  Giuseppe Mulè; Alessandra Sorce; Emilio Nardi; Giulio Geraci; Santina Cottone
Journal:  Intern Emerg Med       Date:  2019-07-15       Impact factor: 3.397

2.  Sacubitril/valsartan reduces ventricular arrhythmias in parallel with left ventricular reverse remodeling in heart failure with reduced ejection fraction.

Authors:  Pieter Martens; Dieter Nuyens; Maximo Rivero-Ayerza; Hugo Van Herendael; Jan Vercammen; Wendy Ceyssens; Evert Luwel; Matthias Dupont; Wilfried Mullens
Journal:  Clin Res Cardiol       Date:  2019-02-20       Impact factor: 5.460

Review 3.  Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.

Authors:  Iris E Beldhuis; Carolyn S P Lam; Jeffrey M Testani; Adriaan A Voors; Harriette G C Van Spall; Jozine M Ter Maaten; Kevin Damman
Journal:  Circulation       Date:  2022-02-28       Impact factor: 39.918

4.  Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation.

Authors:  Qingsong Chen; Yunlin Chen; Fang Qin; Huaan Du; Chunxia Gan; Bei Zhou; Na Wang; Mingyang Xiao; Zhenhong Ou; Wei Zhao; Ben Cui; Zengzhang Liu; Yuehui Yin
Journal:  Front Cardiovasc Med       Date:  2022-05-30

Review 5.  Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors.

Authors:  Juan Brignone; Kasper Bostlund Assersen; Mia Jensen; Boye L Jensen; Brian Kloster; Morten Jønler; Lars Lund
Journal:  Pflugers Arch       Date:  2021-04-12       Impact factor: 3.657

Review 6.  Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid.

Authors:  Andrea Tedeschi; Piergiuseppe Agostoni; Beatrice Pezzuto; Ugo Corra'; Domenico Scrutinio; Rocco La Gioia; Rosa Raimondo; Andrea Passantino; Massimo F Piepoli
Journal:  Eur J Prev Cardiol       Date:  2020-12       Impact factor: 7.804

7.  Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients.

Authors:  Vincenzo Russo; Ernesto Ammendola; Alessio Gasperetti; Roberta Bottino; Marco Schiavone; Daniele Masarone; Giuseppe Pacileo; Gerardo Nigro; Paolo Golino; Gregory Y H Lip; Antonello D'Andrea; Giuseppe Boriani; Riccardo Proietti
Journal:  J Cardiovasc Pharmacol       Date:  2022-04-01       Impact factor: 3.271

8.  The Effect of Sacubitril/Valsartan on Device Detected Arrhythmias and Electrical Parameters among Dilated Cardiomyopathy Patients with Reduced Ejection Fraction and Implantable Cardioverter Defibrillator.

Authors:  Vincenzo Russo; Roberta Bottino; Anna Rago; Andrea Antonio Papa; Biagio Liccardo; Riccardo Proietti; Vincenzo Manna; Paolo Golino; Antonio D'Onofrio; Gerardo Nigro
Journal:  J Clin Med       Date:  2020-04-13       Impact factor: 4.241

Review 9.  Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence.

Authors:  Hong-Mi Choi; Mi-Seung Shin
Journal:  Korean J Intern Med       Date:  2020-04-29       Impact factor: 2.884

Review 10.  Effect of sacubitril/valsartan on renal function: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Francesco Spannella; Federico Giulietti; Andrea Filipponi; Riccardo Sarzani
Journal:  ESC Heart Fail       Date:  2020-09-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.